THE Coca-Cola Company said Monday it is “closely watching” the expanding use of a cannabis element in drinks, another sign cannabis and cannabis-infused products are getting more acceptance in mainstream culture and a harder look from long-established pillars of American business.
The statement came after reports the beverage giant was in talks with a Canadian cannabis company, Aurora Cannabis Inc., to create a health drink infused with cannabidiol, a naturally occurring non-psychoactive compound derived from the cannabis plant.
Cannabidiol, or CBD, does not produce the high commonly associated with marijuana. It is believed by many to have anti-inflammation and pain-relieving properties, and numerous CBD-infused products have emerged recently.
Aurora spokeswoman Heather MacGregor said her company “has expressed specific interest in the infused-beverage space and we intend to enter that market.”
A Coke spokesman said the beverage giant has made no such decision.
“Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. The space is evolving quickly,” Coke spokesman Kent Landers said.
Marijuana becomes legal across Canada on Oct. 17. Cannabis companies from the U.S.—where marijuana remains illegal at the federal level—have flocked to Canada to raise funds and establish businesses there.
Coca Cola’s statement shows the company has learned from its past missteps picking up on new drink trends, said Ali Dibadj, a senior analyst at AllianceBernstein with an expertise in U.S. beverage and snack food companies.
“The company has been caught flat-footed in the past in not keeping up with trends in beverages. They missed the energy drink phenomenon, they missed—and then had to buy into—the functional waters like Vitamin Water and coffee,” Dibadj said. “I think what they’re saying is what they should be saying on this very new and emerging beverage.”
But testing the waters of cannabis-themed drinks could backfire, he said. Many Americans aren’t intimately familiar with the cannabis plant and might not understand that CBD has no psychoactive properties.
“I think you have to be very, very careful with this as a large brand. There are different viewpoints on a product category, and you don’t want to offend too much,” Dibadj said. “You don’t want to be too far ahead on any curve.” AP